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ABSTRACT
Objective: We tested the hypothesis that laparoscopic
inguinal herniorrhaphy using Surgisis mesh secured with
fibrin sealant is an effective long-term treatment for repair
of inguinal hernia. This case series involved 38 adult
patients with 51 inguinal hernias treated in a primary care
center.
Methods: Between December 2002 and May 2005, 38
patients with 45 primary and 6 recurrent inguinal hernias
were treated with laparoscopic repair by the total extra-
peritoneal mesh placement (TEP) technique using Surgisis
mesh secured into place with fibrin sealant. Postoperative
complications, incidence of pain, and recurrence were
recorded, as evaluated at 2 weeks, 6 weeks, 1 year, and
with a follow-up questionnaire and telephone interview
conducted in May and June 2005.
Results: The operations were successfully performed on
all patients with no complications or revisions to an open
procedure. Average follow-up was 13 months (range, 1 to
30). One hernia recurred (second recurrence of unilateral
direct hernia), indicating a 2% recurrence rate.
Conclusions: Laparoscopic repair of inguinal hernia us-
ing Surgisis mesh secured with fibrin sealant can be effec-
tively used to treat primary, recurrent, direct, indirect, and
bilateral inguinal hernias in adults without complications
and minimal recurrence within 1-year of follow-up.
Key Words: Inguinal hernia, Laparoscopy, TEP repair,
Surgisis mesh, Fibrin glue.
INTRODUCTION
Laparoscopic hernia repair using the totally extraperitoneal
(TEP) approach is an effective technique of groin hernia repair
with recurrence rates similar to those of open mesh tech-
niques.1–3 Stapling the mesh to avoid displacement and reduce
recurrence risk has long been thought essential to effect satis-
factory long-term results, although some data suggest that mesh
fixation using tacks or staples is unnecessary.4,5
Mesh fixation using atraumatic means was first described
by Jourdan and Bailey6 in 1998 using cyanoacrylate glue.
More recently, fixation using fibrin sealant has been de-
scribed with positive results in animal models7 and in
humans.5 Fixation using glue decreases the time of the
procedure and minimizes the risk of certain complica-
tions, such as nerve entrapment, osteitis pubis, and hema-
toma.4,5,7 Recently, a significant decrease in the rate of
postoperative chronic pain with glue fixation compared
with pain with tack staples was also reported.5
Surgisis IHM mesh (Cook Surgical, Bloomington, IN), a
biologic hernia graft material composed of purified por-
cine small intestinal submucosa (SIS), was first introduced
to the United States market as an alternative to synthetic
mesh materials. This mesh, composed of extracellular
matrix collagen, fibronectin,8 and associated glycosami-
noglycans9 and growth factors,10,11 has been extensively
investigated in animal models12–14 and used clinically in
multiple surgical procedures, including contaminated
ventral hernia repair15,16 and inguinal hernia repair.17,18 Its
use in laparoscopic repair of inguinal hernia has been
limited, and its compatibility with fibrin glue in these
procedures has not been reported.
The objective of the current study was to evaluate the
effectiveness of laparoscopic repair of inguinal hernia
using Surgisis mesh secured with fibrin sealant in patients
who had undergone TEP. Postoperative complications,
pain duration after surgery, narcotic use, and time to
return to work were recorded, and frequency of long-term
pain and hernia recurrence were also assessed.
METHODS
Between December 2002 and May 2005, all patients pre-
senting with inguinal hernia who were considered candi-
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SCIENTIFIC PAPERdates for laparoscopic repair were offered and given this
procedure. Patients were excluded if they were not can-
didates for a general anesthetic or had prior lower abdom-
inal surgery. Information from the charts of all patients
giving informed consent and undergoing laparoscopic
mesh placement with Surgisis was included in this study.
Between December 2002 and May 2005, 51 inguinal her-
nias (femoral, bilateral, and recurrent included) in 38 pa-
tients were repaired using Surgisis mesh secured with
fibrin sealant. All operations were performed by a single
surgeon, and all operations were performed with the
patient under general anesthesia without antibiotic pro-
phylaxis. Hernias were classified as either primary or re-
current, and of a direct or indirect nature.
Operative Technique
The 2 components of the fibrin sealant (Tisseel, Baxter
Healthcare Corporation, Glendale, CA) were reconstituted
according to the manufacturer’s instructions at the initia-
tion of surgery. Patients were placed in the supine posi-
tion and general endotracheal anesthesia was induced. A
Foley catheter was inserted. The patient’s entire abdomen
was prepped with Betadine and block draped. A curvilin-
ear incision was made near the umbilicus and carried
down to the anterior rectus sheath, which was doubly
grasped, elevated, and incised, entering the rectus sheath.
The rectus muscles were retracted laterally, exposing the
posterior rectus sheath. A peritoneal dissection balloon
trocar (PDB-1, US Surgical, Norwalk, CT) was inserted and
guided by manual and videoscopic guidance down to the
level of the pubis where it was inflated and left inflated for
several minutes for tamponade effect. It was then deflated,
removed and replaced with a structural balloon trocar.
Pneumopreperitoneum was instituted under direct vision.
Two, 5-mm trocars were placed in the middle hypogas-
trium, one suprapubically and the second midway be-
tween the pubis and the umbilicus. Cooper’s ligament was
identified, as were the cord structures and inferior epigas-
tric vessels. The cord structures were skeletonized, and
the hernia sac was reduced off the internal ring down to
the level of the peritoneum.
A vertical line was drawn down the long axis of the
Surgisis mesh by using a surgical marker to assist mesh
orientation during the procedure. A rolled piece of Surgi-
sis ES (7 cm x 10 cm) or Surgisis IHM (8 cm x 13 cm or
10 cm x 15 cm) was placed through the preperitoneum,
unfurled, and placed, uncut, over the myopectinate orifice
after soaking the mesh in saline for 10 minutes to 15
minutes. The 2 solutions of the fibrin sealant were drawn
into separate syringes, which were then fitted into the
laparoscopic applicator, Duplocath 35 M.I.C. (Baxter AG,
Vienna, Austria). Once the mesh was deployed in the
position desired, it was secured to the pubic bone (Coo-
per’s ligament) in the midline, the lacunar ligament, later-
ally, and superiorly into the transversalis fascia with the
fibrin sealant, which was allowed to set for several min-
utes. The posterior aspect of the matrix repair was then
held in place as the pneumopreperitoneum was released
under direct vision, observing the peritoneum to obtain its
desired position relative to the matrix repair. All trocars
were then removed. The skin incisions were closed with
Dermabond skin adhesive (Ethicon, Somerville, NJ). Pa-
tients were then removed to the recovery room.
Patient demographic data (age, sex, and history of alcohol
and tobacco use), postoperative complications, pain du-
ration after surgery, narcotic usage (# of doses of Percocet
5/325 taken postoperatively), and time to return to work
were recorded. Postoperative visits were performed at 2
weeks and 6 weeks. In May to June 2005, patients were
asked to complete an open-ended, free-form question-
naire to further assess the frequency and persistence of
any long-term pain. Recurrence was also assessed at this
time by directly contacting the patients and asking them if
they had seen any evidence of hernia recurrence or had
concerns that their hernia had recurred. They were also
asked specifically if they had seen another physician for a
new hernia. Patients were only examined for recurrence at
follow-up if they were unable to verbally express with
certainty whether or not their hernia had recurred.
RESULTS
Of the 38 patients, 35 were men and 3 were women. Their
average age was 49 years, and the majority were non-
smokers. Of the 51 hernias repaired, 45 were primary and
6 were recurrent. Most hernias (43, 84.3%) were classified
as indirect. Demographic data and hernia classification are
displayed in Table 1.
All patients could care for themselves within a day of
surgery. Immediately following surgery, patients on aver-
age took 7 days off from work, though 21 patients (55%)
rested for less than a week (Table 2). One patient who
had undergone bilateral hernia repair was off work for 4
weeks. Short-term pain associated with the procedure
generally subsided completely within 3 days to 4 days,
though 1 patient complained of postoperative pain for 2
weeks, which was controlled by a narcotic prescription in
which 28 doses were used. Follow-up examination 2
weeks after the surgery revealed no swelling or localized
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and returned to work.
Postoperative complications were minor and generally
expected as a consequence of surgery (Table 3). Mild
cord or canal swelling, or both, following the procedure
was the most common complaint. In no patient was the
degree of swelling judged as severe or necessitating inter-
vention. Mild to moderate orchitis was noted in 3 patients
(7.9%) following surgery, as were 2 cases of hematoma
(5.3%) and 1 suspected case of seroma (2.6%) that re-
solved without intervention. Two patients (5.3%) pre-
sented with mild fever and localized pain and swelling
following surgery. Ciprofloxacin was given for suspected
infection, and both patients eventually resolved without
further intervention.
Three patients (7.9%) reported frequent chronic pain 12
months to 18 months postoperatively. Two of these pa-
tients had bilateral indirect hernia repairs and are 12
months and 18 months postoperative without recurrence.
The third patient had a repair of a recurrent direct hernia;
this patient is 12 months postoperative, and the hernia has
again recurred. This is the only recurrence (2%) noted in
this series, with an average follow-up of 136 months
(range, 1 to 30).
DISCUSSION
Surgisis is a new biologic mesh for hernia repair that
gradually incorporates into the patient’s body wall and
forms a strong repair consisting entirely of organized fi-
brovascular tissue without the persistence of a foreign
body that can lead to eventual infection. In animal mod-
els, the mesh is gradually replaced by organized connec-
tive tissue and can no longer be detected after approxi-
mately 6 months, even though the strength of the repair is
maintained at least as long as up to 2 years.13,19 To date, its
compatibility with fibrin sealant in laparoscopic inguinal
hernia repair has not been reported. In this series, we
evaluated the effectiveness of laparoscopic repair of in-
guinal hernia using Surgisis mesh secured with fibrin seal-
ant in patients who had undergone TEP.
Fixation of mesh using glue has several advantages over
tacks or staples. Although we didn’t measure the operative
time, others have reported that the use of glue decreases
the time of the procedure and minimizes the risk of certain
complications, such as nerve entrapment, osteitis pubis,
and hematoma.4,5,7 A significant decrease in the rate of
postoperative chronic pain with glue fixation as compared
with tack staples has also been reported.5
Table 1.
Patient Demographic Data and Hernia Classification
Characteristic Patients (n  38)
Age, mean years (range) 49 (24–82)
Male/Female 35/3
Smoke (Y/N/Not Available) 7/23/8
Alcohol (Y/N/Not Available) 11/15/12
Hernia type
Primary (%) 45 (88.2)
Recurrent (%) 6 (11.8)
Patient Hernia Number
Unilateral (%) 25 (65.8)
Bilateral (%) 13 (34.2)
General Hernia Classification
Direct (%) 7 (13.7)
Indirect (%) 43 (84.3)
Pantaloon (%) 1 (2.0)
Table 2.
Follow-up Variables
Characteristics Number
Pain Duration, d  SD 3.23.6
Narcotic Usage, #  SD 710
Return to Work, d  SD 76
5d 2 1
10 d 9
Table 3.
Postoperative Complications
Complication Number
Chronic Persistent Pain 3
Orchitis 3
Hematoma 2
Infection 2
Cord/Canal Edema
None 22
Mild 15
Moderate 1
Severe 0
Seroma 1
Recurrence 1
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pain 12 months to18 months following their procedures.
Although this incidence of chronic pain is higher than
reported elsewhere for TEP procedures in which the mesh
was affixed with fibrin sealant (4.5%),5 it is still lower than
the 9.2% to 14.7% pain incidence reported when staples
were used,5,20 and much less than up to 62% chronic pain
reported with open repair techniques.21,22 However, in
other reports where Surgisis mesh was used in Lichten-
stein repair of inguinal hernia, incidence of pain was
lower compared with pain from polypropylene mesh.17,18
Recent literature points to the emergence of “meshomas”
secondary to placement of prosthetic mesh in hernia re-
pairs as a source of chronic pain.23 This phenomenon, due
to nonfixation, insufficient fixation, or insufficient dissec-
tion, results in folding and wrinkling of the mesh, a pro-
cess that continues until the mesh is wadded up into a
ball. The mechanical pressure of this abrasive material on
the adjacent tissues may lead to chronic postsurgical pain
that is only relieved if the mesh is removed. Because
Surgisis mesh is a biologic material that completely re-
models, the risk of forming a foreign-body meshoma is
minimized with this material, and the ensuing loss of
repair integrity is eliminated.
There were no reports of osteitis pubis, nerve or vascular
injury, or bowel lesions in this series. We noted 2 cases of
hematoma (5.3%), 1 seroma (2.6%), and 3 mild cases of
orchitis (7.9%), all of which resolved without intervention.
These incidences compare favorably with those reported
by Topart et al,5 who noted seroma in 12% of cases and
hematoma in 4.5% of cases. Only one recurrence was
reported, at 12 months postoperative, and this was in a
patient who was treated for a recurrent direct hernia.
Because patients were asked to self-examine themselves
and were only asked to return to the clinic if they were
equivocal about recurrence, it is possible that asymptotic
recurrences were missed.
Surgisis mesh has been shown to gradually remodel into
native body wall over a span of 6 months and also that the
strength of the repair remains after as long as 2 years.13,19
Even though the current results are preliminary and the
average follow-up was limited to 13 months, it is note-
worthy that the combination of fibrin glue and a biologic
mesh can be effective in TEP repair out to a follow-up
time that exceeds the time it takes for the mesh to be
completely replaced by the patient’s own tissues. Even
though tissue biopsies were not obtained to show that the
mesh and glue were completely remodeled, the animal
data suggest that the only tissue remaining at the 13-
month time-point would be entirely patient tissue. Longer-
term follow-up in other human case series has generally
supported this hypothesis.15,24
CONCLUSIONS
Laparoscopic repair of inguinal hernia using Surgisis mesh
secured with fibrin sealant can be effectively used to treat
primary, recurrent, direct, indirect, and bilateral inguinal
hernias in adults without unexpected complications and
minimal incidence of recurrence in a short-term follow-
up. Complications noted in this series were typical of the
operation, similar in incidence to those rates reported in
the literature, and resolved without surgical intervention.
The 2% short-term recurrence rate is promising and indi-
cates that fibrin glue can be used effectively to secure
biologic mesh, such as Surgisis, in laparoscopic inguinal
hernia repair using the TEP technique. Longer term fol-
low-up is necessary to fully establish the efficacy of this
technique.
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